Skip to content

SW · GIVN.SW · CHEMICALS - SPECIALTY

Givaudan S.A. (GIVN.SW) intrinsic value and stock valuation

$4,049.00as of 2026-11-21 · Mkt cap 26.77B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Givaudan S.A. DCF and intrinsic value

InvestorsCraft values GIVN.SW with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from GIVN.SW’s statements →

Givaudan S.A. Graham Number

Graham Number: $1,131.59d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Chemicals - Specialty Vernier 1214 givaudan.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$7.47B+3.4% 5y CAGRd
20112025
Net income
$1.07B+7.6% 5y CAGRd
20112025
Free cash flow
$1.21B+7.1% 5y CAGRd
20112025
Total equity
$4.57B+5.4% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$7.47B$7.41B$6.92B$7.12B$6.68B
Operating income$1.38B$1.39B$1.12B$1.09B$1.09B
Net income$1.07B$1.09B$893M$856M$821M
EPSd$115.5M$117.6M$96.4M$92.5M$88.4M
Operating cash flow$1.51B$1.63B$1.37B$892M$1.23B
Capital expenditure-$-305M-$-293M-$-275M-$-304M-$-256M
Free cash flow$1.21B$1.33B$1.1B$588M$969M
Total assets$11.9B$12.1B$11.1B$11.5B$11.4B
Total debt$4.42B$4.75B$4.91B$5.01B$4.67B
Net debt$3.68B$4B$4.31B$4.53B$4.4B
Total equity$4.57B$4.58B$4B$4.24B$3.94B
Cash and short-term investments$742M$762M$608M$488M$278M
Income statement
20252024202320222021
Revenue$7.47B$7.41B$6.92B$7.12B$6.68B
Cost of revenue$4.22B$4.14B$4.2B$4.48B$3.99B
Gross profit$3.25B$3.27B$2.72B$2.64B$2.7B
Research and development expenses$551M$565M$519M$477M$498M
Selling, general and administrative expenses$1.23B$1.22B$1.1B$1.11B$1.16B
Other expenses$90M$96M-$-15M-$-24M-$-31M
Operating expenses$1.87B$1.88B$1.6B$1.54B$1.61B
Cost and expenses$6.09B$6.02B$5.8B$6.03B$5.6B
Interest income$19M$26M$8M$11M$8M
Interest expense$113M$114M$114M$95M$89M
Depreciation and amortization$369M$359M$356M$364M$391M
Ebitda$1.79B$1.79B$1.47B$1.38B$1.44B
Operating income$1.38B$1.39B$1.12B$1.09B$1.09B
Total other income/expenses, net-$-76M-$-81M-$-127M-$-184M-$-124M
Income before tax$1.31B$1.31B$989M$917M$963M
Income tax expense$234M$223M$96M$72M$144M
Net income$1.07B$1.09B$893M$856M$821M
Weighted average shares outstanding$9.27M$9.22M$9.22M$9.22M$9.22M
Weighted average diluted shares outstanding$9.27M$9.27M$9.26M$9.25M$9.29M
Balance sheet
20252024202320222021
Cash and short-term investments$742M$762M$608M$488M$278M
Net receivables$1.62B$1.68B$1.45B$1.58B$1.52B
Inventory$1.43B$1.43B$1.28B$1.42B$1.38B
Total current assets$4.07B$4.21B$3.62B$3.71B$3.41B
Property, plant and equipment, net$2.35B$2.38B$2.24B$2.29B$2.3B
Goodwill and intangible assets$4.72B$4.83B$4.46B$8.07B$8.38B
Long-term investments$310M$140M$418M$483M$371M
Total non-current assets$7.79B$7.89B$7.51B$7.8B$8.03B
Total assets$11.9B$12.1B$11.1B$11.5B$11.4B
Accounts payable$1.2B$1.12B$891M$861M$1.01B
Short-term debt$231M$819M$442M$356M$429M
Deferred revenue$0.00$0.00$136M$123M$188M
Total current liabilities$2.35B$2.83B$2.06B$1.97B$2.32B
Long-term debt$4.19B$3.93B$4.46B$4.65B$4.24B
Deferred revenue, non-current$0.00$0.00$0.00$352M$0.00
Total non-current liabilities$4.95B$4.69B$5.07B$5.3B$5.17B
Capital lease obligations$406M$423M$407M$401M$404M
Total liabilities$7.3B$7.52B$7.13B$7.27B$7.49B
Common stock$92M$92M$92M$92M$92M
Retained earnings$7.41B$6.97B$6.73B$6.61B$6.37B
Accumulated other comprehensive income (loss)-$-2.93B-$-2.45B-$-2.63B-$-2.25B-$-2.32B
Total equity$4.57B$4.58B$4B$4.24B$3.94B
Total investments$314M$153M$426M$496M$375M
Total debt$4.42B$4.75B$4.91B$5.01B$4.67B
Net debt$3.68B$4B$4.31B$4.53B$4.4B
Cash flow statement
20252024202320222021
Net income$1.07B$1.09B$893M$856M$821M
Depreciation and amortization$369M$359M$356M$364M$391M
Stock-based compensation$52M$59M$29M$18M$67M
Change in working capital$43M-$-43M-$-23M-$-328M-$-166M
Accounts receivable-$-39M-$-191M-$-112M-$-112M-$-93M
Inventory-$-83M-$-126M$43M-$-82M-$-165M
Accounts payable$0.00$187M$105M-$-95M$167M
Net cash provided by operating activities$1.51B$1.63B$1.37B$892M$1.23B
Investments in property, plant and equipment-$-249M-$-236M-$-215M-$-304M-$-256M
Acquisitions, net-$-218M-$-229M$2M$8M-$-397M
Net cash used for investing activities-$-380M-$-448M-$-467M-$-451M-$-921M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased$0.00-$-35M-$-29M-$-51M-$-69M
Dividends paid-$-645M-$-627M-$-617M-$-607M-$-589M
Net cash used for financing activities-$-1.11B-$-1.03B-$-699M-$-229M-$-440M
Net change in cash-$-11M$149M$125M$201M-$-137M
Cash at end of period$738M$749M$600M$475M$274M
Operating cash flow$1.51B$1.63B$1.37B$892M$1.23B
Capital expenditure-$-305M-$-293M-$-275M-$-304M-$-256M
Free cash flow$1.21B$1.33B$1.1B$588M$969M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Givaudan S.A.

        Givaudan SA, together with its subsidiaries, manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through in divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances, consumer products, and fragrance ingredients and active beauty products. The Taste & Wellbeing division provides beverages, such as carbonated soft drinks, juices, bottled waters, ready-to-drink products, alcoholic beverages, hot drinks, and others; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks comprising rice crackers and cassava chips; savory and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. The company was founded in 1796 and is headquartered in Vernier, Switzerland.

        CEO
        Christian Stammkoetter
        Employees
        16.94K
        Beta
        0.66

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Givaudan S.A. (GIVN.SW)?

        InvestorsCraft does not currently publish an intrinsic value for GIVN.SW. How the IC value is calculated.

        Is GIVN.SW undervalued?

        InvestorsCraft does not publish an undervaluation signal for GIVN.SW at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.